Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDLineage Cell Therapeutics Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | -$0.03 | -$0.01 | -$0.02 |
| Q2 2026 | 3 | -$0.01 | -$0.01 | -$0.01 |
| Q3 2026 | 3 | -$0.04 | -$0.01 | -$0.03 |
| Q4 2026 | 1 | -$0.01 | -$0.00 | -$0.01 |
| Q1 2027 | 1 | -$0.04 | -$0.01 | -$0.03 |
| Q2 2027 | 1 | -$0.04 | -$0.01 | -$0.03 |
| Q3 2027 | 1 | -$0.04 | -$0.01 | -$0.03 |
| Q4 2027 | 1 | -$0.05 | -$0.01 | -$0.03 |
| Q1 2028 | 1 | -$0.05 | -$0.01 | -$0.03 |
| Q2 2028 | 1 | -$0.05 | -$0.01 | -$0.03 |
| Q3 2028 | 1 | -$0.05 | -$0.01 | -$0.03 |
| Q4 2028 | 1 | -$0.05 | -$0.01 | -$0.03 |
Lineage Cell Therapeutics Inc Earnings Date And Information
Lineage Cell Therapeutics Inc last posted its earnings results on Tuesday, May 12th, 2026. The company reported $-0.03 earnings per share for the quarter, missing analysts' consensus estimates of $-0.02 by $0.01. The company had revenue of 1.73 M for the quarter and had revenue of 14.56 M for the year. Lineage Cell Therapeutics Inc has generated $0 earnings per share over the last year ($-0.28 diluted earnings per share) and currently has a price-to-earnings ratio of -4.65. Lineage Cell Therapeutics Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Lineage Cell Therapeutics Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/12/2026 | Q1 2026 | -$0.02 | -$0.02 | 0 | $3.60 M | $1.73 M |
| 03/05/2026 | Q4 2025 | -$0.04 | $0.00 | 0.05 | $1.97 M | $6.61 M |
| 11/06/2025 | Q3 2025 | -$0.02 | -$0.13 | -0.11 | $2.30 M | $3.68 M |
| 08/12/2025 | Q2 2025 | -$0.02 | -$0.13 | -0.11 | $1.47 M | $2.77 M |
| 05/13/2025 | Q1 2025 | -$0.02 | -$0.02 | 0 | $1.72 M | $1.50 M |
| 03/10/2025 | Q4 2024 | -$0.04 | -$0.02 | 0.02 | $1.62 M | $2.87 M |
| 11/14/2024 | Q3 2024 | -$0.01 | -$0.02 | -0 | $1.03 M | $3.78 M |
| 08/08/2024 | Q2 2024 | -$0.05 | -$0.03 | 0.02 | $943.20 K | $1.41 M |
| 05/09/2024 | Q1 2024 | -$0.04 | -$0.04 | 0 | $1.36 M | $1.44 M |
| 03/07/2024 | Q4 2023 | -$0.02 | -$0.03 | -0 | N/A | $2.09 M |
| 11/09/2023 | Q3 2023 | -$0.04 | -$0.04 | -0 | N/A | $1.25 M |
| 08/10/2023 | Q2 2023 | -$0.02 | -$0.03 | -0.01 | N/A | $3.23 M |
| 05/11/2023 | Q1 2023 | -$0.02 | -$0.03 | -0 | N/A | $2.39 M |
| 03/09/2023 | Q4 2022 | -$0.03 | -$0.04 | -0.01 | N/A | $1.92 M |
| 11/10/2022 | Q3 2022 | -$0.04 | -$0.04 | -0 | N/A | $3.00 M |
| 08/11/2022 | Q2 2022 | -$0.04 | -$0.06 | -0.02 | N/A | $4.55 M |
| 05/12/2022 | Q1 2022 | -$0.03 | -$0.05 | -0.01 | N/A | $5.24 M |
| 03/10/2022 | Q4 2021 | -$0.01 | -$0.17 | -0.16 | N/A | $960.00 K |
| 11/10/2021 | Q3 2021 | -$0.05 | -$0.05 | 0 | N/A | $2.20 M |
| 08/12/2021 | Q2 2021 | -$0.03 | -$0.03 | -0 | N/A | $441.00 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Lineage Cell Therapeutics Inc Earnings: FAQ's
The conference call for Lineage Cell Therapeutics Inc's latest earnings report can be listened to online.
The conference call transcript for Lineage Cell Therapeutics Inc's latest earnings report can be read online.
Lineage Cell Therapeutics Inc (:LCTX) has a recorded annual revenue of $14.56 M.
Lineage Cell Therapeutics Inc (:LCTX) has a recorded net income of $-63,533,000.Lineage Cell Therapeutics Inc has generated $-0.28 earnings per share over the last four quarters.
Lineage Cell Therapeutics Inc (:LCTX) has a price-to-earnings ratio of -4.65 and price/earnings-to-growth ratio is 0.04.